Anmei Zhang

1.0k total citations
26 papers, 495 citations indexed

About

Anmei Zhang is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Anmei Zhang has authored 26 papers receiving a total of 495 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Oncology, 10 papers in Pulmonary and Respiratory Medicine and 8 papers in Molecular Biology. Recurrent topics in Anmei Zhang's work include Lung Cancer Treatments and Mutations (5 papers), Cancer Immunotherapy and Biomarkers (4 papers) and CAR-T cell therapy research (3 papers). Anmei Zhang is often cited by papers focused on Lung Cancer Treatments and Mutations (5 papers), Cancer Immunotherapy and Biomarkers (4 papers) and CAR-T cell therapy research (3 papers). Anmei Zhang collaborates with scholars based in China, Germany and United States. Anmei Zhang's co-authors include Yuguo Weng, Roland Hetzer, Fan Ye, Xinxin Wang, Yingbin Xiao, Jian Sun, Ye Fan, Yingbin Xiao, Hu Ma and Zhengtang Chen and has published in prestigious journals such as Nature Communications, IEEE Transactions on Image Processing and Science Translational Medicine.

In The Last Decade

Anmei Zhang

25 papers receiving 486 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Anmei Zhang China 13 157 113 92 89 78 26 495
Kazutoshi Mawatari Japan 9 107 0.7× 60 0.5× 44 0.5× 44 0.5× 67 0.9× 22 346
Juan Yu China 13 170 1.1× 150 1.3× 215 2.3× 70 0.8× 58 0.7× 29 515
Xiaowei Liu China 16 197 1.3× 188 1.7× 74 0.8× 63 0.7× 54 0.7× 44 548
Poonam Malhotra India 13 88 0.6× 142 1.3× 70 0.8× 144 1.6× 24 0.3× 39 556
Naoya Tomatsuri Japan 14 251 1.6× 105 0.9× 40 0.4× 249 2.8× 70 0.9× 31 681
Lihua Shang China 13 266 1.7× 91 0.8× 269 2.9× 59 0.7× 31 0.4× 33 640
Zhengyu Jiang China 17 318 2.0× 85 0.8× 90 1.0× 63 0.7× 28 0.4× 42 707
Yoshifumi Yokoyama Japan 13 168 1.1× 158 1.4× 120 1.3× 253 2.8× 73 0.9× 37 682

Countries citing papers authored by Anmei Zhang

Since Specialization
Citations

This map shows the geographic impact of Anmei Zhang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anmei Zhang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anmei Zhang more than expected).

Fields of papers citing papers by Anmei Zhang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anmei Zhang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anmei Zhang. The network helps show where Anmei Zhang may publish in the future.

Co-authorship network of co-authors of Anmei Zhang

This figure shows the co-authorship network connecting the top 25 collaborators of Anmei Zhang. A scholar is included among the top collaborators of Anmei Zhang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anmei Zhang. Anmei Zhang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chen, Lu, Wen Li, Xinwei Diao, et al.. (2025). Modified Target Delineation and Moderately Hypofractionated Radiotherapy for High-Grade Glioma. JAMA Network Open. 8(7). e2523053–e2523053.
2.
Gao, Jianbao, Tao Jiang, Jin Zheng, et al.. (2024). NK cell transfer overcomes resistance to PD-(L)1 therapy in aged mice. Experimental Hematology and Oncology. 13(1). 48–48. 8 indexed citations
3.
Hu, Chunyan, Anmei Zhang, Xinxin Wang, et al.. (2023). A real-world retrospective study of incidence and associated factors of endocrine adverse events related to PD-1/PD-L1 inhibitors. Annals of Translational Medicine. 11(4). 164–164. 3 indexed citations
4.
Yang, Jingyun, Yu Wang, Wenying Liu, et al.. (2023). Identification of the shared gene signatures and molecular mechanisms between multiple sclerosis and non-small cell lung cancer. Frontiers in Immunology. 14. 1180449–1180449. 2 indexed citations
5.
Cui, Tianxiang, Anmei Zhang, Lü Chen, et al.. (2023). Feasibility of omitting the clinical target volume under PET-CT guidance in unresectable stage III non-small-cell lung cancer: A phase II clinical trial. Radiotherapy and Oncology. 181. 109505–109505. 5 indexed citations
6.
Zhang, Anmei, et al.. (2023). Promoting Monocular Depth Estimation by Multi-Scale Residual Laplacian Pyramid Fusion. IEEE Signal Processing Letters. 30. 205–209. 4 indexed citations
7.
Zhang, Jing, Xianli Wu, Anmei Zhang, et al.. (2022). Primary Mediastinal Large B-Cell Lymphoma Achieved by Non-Cautery Assisted Transbronchial Mediastinal Cryobiopsy. Respiration. 101(7). 683–687. 8 indexed citations
8.
Zhang, Anmei & Jian Sun. (2021). Joint Depth and Defocus Estimation From a Single Image Using Physical Consistency. IEEE Transactions on Image Processing. 30. 3419–3433. 20 indexed citations
9.
Jia, Qingzhu, Qian Chu, Anmei Zhang, et al.. (2021). Mutational burden and chromosomal aneuploidy synergistically predict survival from radiotherapy in non-small cell lung cancer. Communications Biology. 4(1). 131–131. 12 indexed citations
10.
Zhang, Anmei, et al.. (2019). Somatosensory stimulation treatments for postoperative analgesia of mixed hemorrhoids. Medicine. 98(6). e14441–e14441. 6 indexed citations
11.
Zou, Hongbo, Anmei Zhang, Songtao Wang, et al.. (2019). MPC1 deficiency accelerates lung adenocarcinoma progression through the STAT3 pathway. Cell Death and Disease. 10(3). 148–148. 26 indexed citations
12.
Wang, Xinxin, Jianbao Gao, Haixia Long, et al.. (2018). Centromere protein U expression promotes non-small-cell lung cancer cell proliferation through FOXM1 and predicts poor survival. Cancer Management and Research. Volume 10. 6971–6984. 23 indexed citations
13.
Zhang, Xian, Binkui Li, Abdol Hossein Rezaeian, et al.. (2017). H3 ubiquitination by NEDD4 regulates H3 acetylation and tumorigenesis. Nature Communications. 8(1). 14799–14799. 35 indexed citations
16.
Sun, Jianguo, Hu Ma, Anmei Zhang, et al.. (2014). Monitoring microRNAs Using a Molecular Beacon in CD133+/CD338+Human Lung Adenocarcinoma-initiating A549 Cells. Asian Pacific Journal of Cancer Prevention. 15(1). 161–166. 12 indexed citations
17.
Zhang, Anmei, Ye Fan, Xinxin Wang, et al.. (2012). Increased treatment-related mortality with additional cisplatin-based chemotherapy in patients with nasopharyngeal carcinoma treated with standard radiotherapy. Radiotherapy and Oncology. 104(3). 279–285. 27 indexed citations
18.
Zhang, Anmei, Yé Fan, Hu Ma, et al.. (2012). Identification of a Cancer Stem-like Population in the Lewis Lung Cancer Cell Line. Asian Pacific Journal of Cancer Prevention. 13(3). 761–766. 8 indexed citations
19.
Ye, Fan, Anmei Zhang, Yingbin Xiao, Yuguo Weng, & Roland Hetzer. (2010). Glucose–insulin–potassium therapy in adult patients undergoing cardiac surgery: a meta-analysis. European Journal of Cardio-Thoracic Surgery. 40(1). 192–199. 45 indexed citations
20.
Ye, Fan, Anmei Zhang, Yingbin Xiao, Yuguo Weng, & Roland Hetzer. (2009). Warm versus cold cardioplegia for heart surgery: a meta-analysis. European Journal of Cardio-Thoracic Surgery. 37(4). 912–919. 68 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026